Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

  1. Home
  2. Homepage
Filter by
  • Filter by
  • Remove this filter Infectious disease: Healthcare-associated infections
  • Remove this filter Tag: EU/EEA
  • Remove this filter Tag: Sweden
  • Remove this filter Tag: Sweden
  • Infectious disease
    • Healthcare-associated infections (2)
    • Travel related infections (1)
    • Methicillin-resistant Staphylococcus aureus (MRSA) (1)
    • Nosocomial infections (1)
    • Klebsiella pneumoniae (1)
  • Public health area
    • Public health threat (2)
    • Outbreak (2)
    • Threats and outbreaks (2)
    • Scientific advice (1)
    • Travellers' health (1)
    • Infectious diseases on aircrafts (1)
    • Antimicrobial resistance (1)
    • Antibiotic resistance (1)
  • Country
    • Europe (2)
      • EU/EEA (2)
        • Sweden (2)
        • Finland (1)
        • Ireland (1)
        • Norway (1)
        • Spain (1)
        • United Kingdom (1)
      • Sweden (2)
      • Finland (1)
      • Ireland (1)
      • Norway (1)
      • Spain (1)
      • United Kingdom (1)
    • Asia (1)
    • Africa (1)
    • Americas (1)
  • Type
    • Publication (1)
    • Risk assessment (1)
    • News (1)
    • ECDC comment (1)
  • Page 1 of 1 // 2 Results found
    • Sort by:

News

Imported methicillin-resistant Staphylococcus aureus, SwedenArchived

ECDC comment - 13 May 2011

The authors analyzed data on 444 imported cases of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden during the period 2000-2003. The risk for MRSA carriage or infection in returning travellers ranged from 0.1 per million travellers returning from Nordic countries to 59.4 per million travellers returning from North Africa and the Middle East. 

  • Eastern Asia
  • Europe
  • Ireland
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Middle East
  • Northern Africa
  • Public health threat
  • South America
  • Sweden
  • Travellers' health
  • United Kingdom

Publication

Rapid risk assessment: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain

Risk assessment - 11 Jul 2018

This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.

RRA: Carbapenemase-producing (OXA-48) Klebsiella pneumoniae ST392 in travellers previously hospitalised in Gran Canaria, Spain - EN - [PDF-1.04 MB]
  • Antimicrobial resistance
  • Finland
  • Healthcare-associated infections
  • Klebsiella pneumoniae
  • Norway
  • Public health threat
  • Scientific advice
  • Spain
  • Sweden
  • Travel related infections
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2019
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us